التفاصيل البيبلوغرافية
| العنوان: |
Vascular effects of natriuretic peptides in healthy men. |
| المؤلفون: |
Komarek, Marius, Bernheim, Alain, Schindler, Ruth, Steden, Renate, Kiowski, Wolfgang, Rocca, Hans Peter Brunner-La, Brunner-La Rocca, Hans Peter |
| المصدر: |
Journal of Cardiovascular Pharmacology & Therapeutics; Dec2004, Vol. 9 Issue 4, p263-270, 8p |
| مصطلحات موضوعية: |
ATRIAL natriuretic peptides, VASODILATION, HEMODYNAMICS, CARDIOVASCULAR pharmacology, GUANYLATE cyclase, PEPTIDE hormones, HEART atrium, ENZYMES, CELL receptors, CLINICAL trials, COMPARATIVE studies, RESEARCH methodology, MEDICAL cooperation, RESEARCH, EVALUATION research, NATRIURETIC peptides, PHYSIOLOGY, CELL physiology |
| مستخلص: |
Background: Most effects of atrial (ANP) and B-type natriuretic peptide (BNP) result from stimulation of the guanylyl-cyclase type A receptor. Chronic elevation causes hyporesponsiveness to ANP, whereas BNP effects tend to be preserved, implying an additional pathway of action. We, therefore, investigated the hemodynamic effects of co-infusion of ANP, BNP, and, as a positive control acting on type B receptor, C-type natriuretic peptide (CNP). Furthermore, vascular responses to short and prolonged infusions were compared to investigate rapid hyporesponsiveness of guanylyl-cyclase type A receptor.Methods: In 11 healthy volunteers, arterial response to continuous intra-arterial infusion of ANP (60 pmol/100 mL forearm tissue volume [FAV]/min) was assessed by venous occlusion plethysmography. Then, co-infusion of a similar dose of ANP, BNP, or CNP was administered in randomized order. Each infusion phase was followed by a washout period. Then, ANP was restarted, followed by co-infusion of one of the natriuretic peptides not yet infused. After a further washout period, ANP was restarted, followed by co-infusion of the natriuretic peptide not yet co-infused. In 6 subjects, infusion time was adjusted to plasma half-lives (5 times), and in the other 5 subjects, infusion time was 5 minutes.Results: ANP alone caused the expected vasodilation from 2.7 +/- 0.3 mL/min/100 mL FAV to 6.0 +/- 0.9 mL/min/100 mL FAV (P < .004). This response remained unchanged in the group that received short-term infusions (6.2 +/- 0.8 mL/min/100 mL FAV to 6.6 +/- 1.1 mL/min/100mL FAV) but was reduced over time in the group receiving longer-term infusions (6.5 +/- 1.2 mL/min/100 mL FAV to 4.5 +/- 0.7 mL/min/100mL FAV, P < .05; difference between groups P < .05). Co-infusions of ANP, BNP, and CNP caused minor additional vasodilation (mean 0.8 +/- 0.2 mL/min/100ml FAV, P < .01), which did not differ between the different co-infused natriuretic peptides.Conclusion: Our data provide evidence for rapid desensitization of the guanylyl-cyclase type A receptor in humans, but do not support the presence of a BNP-specific receptor. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Cardiovascular Pharmacology & Therapeutics is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
